Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2

References

• McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73 (Suppl 1):4–13.
   PubMed Web of Science ®Google Scholar
• Kloeckner R, Galle PR, Bruix J. Local and regional therapies for hepatocellular carcinoma. Hepatology. 2021;73(S1):137–149.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.
   PubMed Web of Science ®Google Scholar
• Shin SW, Ahn KS, Kim SW, et al. Liver resection versus local ablation therapies for hepatocellular carcinoma within the Milan criteria: a systematic review and meta-analysis. Ann Surg. 2021;273(4):656–666.
   PubMed Web of Science ®Google Scholar
• Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564–571.
   PubMed Web of Science ®Google Scholar
• Kong J, Kong J, Pan B, et al. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1alpha/VEGFA. PLoS One. 2012;7(5):e37266.
   PubMed Web of Science ®Google Scholar
• Kong J, Kong L, Kong J, et al. After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma. J Transl Med. 2012;10(1):230.
   PubMed Web of Science ®Google Scholar
• Kong J, Yao C, Ding X, et al. ATPase inhibitory factor 1 promotes hepatocellular carcinoma progression after insufficient radiofrequency ablation, and attenuates cell sensitivity to sorafenib therapy. Front Oncol. 2020;10:1080.
   PubMed Web of Science ®Google Scholar
• Tan L, Chen S, Wei G, et al. Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner. Cancer Lett. 2019;460:29–40.
   PubMed Web of Science ®Google Scholar
• Wan J, Wu W, Chen Y, et al. Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/akt/HIF-1alpha signals. Acta Biochim Biophys Sin (Shanghai). 2016;48(4):371–377.
   PubMed Web of Science ®Google Scholar
• Fagiani E, Christofori G. Angiopoietins in angiogenesis. Cancer Lett. 2013;328(1):18–26.
   PubMed Web of Science ®Google Scholar
• Reiss Y. Angiopoietins. Recent Results Cancer Res. 2010;180:3–13.
   PubMedGoogle Scholar
• Sanz MA, Fenaux P, Tallman MS, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019;133(15):1630–1643.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhou B, Luo H, et al. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling. Theranostics. 2019;9(15):4391–4408.
   PubMed Web of Science ®Google Scholar
• Wang HY, Zhang B, Zhou JN, et al. Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex. Cell Death Dis. 2019;10(6):453.
   PubMed Web of Science ®Google Scholar
• Jiang F, Wang X, Liu Q, et al. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Toxicol Lett. 2014;231(1):55–61.
   PubMed Web of Science ®Google Scholar
• Cai X, Yu L, Chen Z, et al. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1. Cancer Biomark. 2020;28(2):221–230.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hu B, Sun YF, et al. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Clin Transl Med. 2021;11(2):e335.
   PubMed Web of Science ®Google Scholar
• Hines-Peralta A, Sukhatme V, Regan M, et al. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Radiology. 2006;240(1):82–89.
   PubMed Web of Science ®Google Scholar
• Seong NJ, Yoon CJ, Kang SG, et al. Effects of arsenic trioxide on radiofrequency ablation of VX2 liver tumor: intraarterial versus intravenous administration. Korean J Radiol. 2012;13(2):195–201.
   PubMed Web of Science ®Google Scholar
• Horkan C, Ahmed M, Liu Z, et al. Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model. J Vasc Interv Radiol. 2004;15(3):269–274.
   PubMed Web of Science ®Google Scholar
• Sönksen M, Kerl K, Bunzen H. Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors. Med Res Rev. 2022;42(1):374–398.
   PubMed Web of Science ®Google Scholar
• Liu B, Pan S, Dong X, et al. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci. 2006;97(7):675–681.
   PubMed Web of Science ®Google Scholar
• Haybar H, Shahrabi S, Rezaeeyan H, et al. Strategies to inhibit arsenic trioxide-induced cardiotoxicity in acute promyelocytic leukemia. J Cell Physiol. 2019;234(9):14500–14506.
   PubMed Web of Science ®Google Scholar
• Kulik-Kupka K, Koszowska A, Bronczyk-Puzon A, et al. [Arsenic - Poison or medicine?]. Med Pr. 2016;67(1):89–96.
   PubMed Web of Science ®Google Scholar
• Morse MA, Sun W, Kim R, et al. The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res. 2019;25(3):912–920.
   PubMed Web of Science ®Google Scholar
• Yu X, Ye F. Role of angiopoietins in development of cancer and neoplasia associated with viral infection. Cells. 2020;9(2):457.
   PubMed Web of Science ®Google Scholar
• Lin N, Meng L, Lin J, et al. Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1. J Cell Biochem. 2020;121(2):1441–1451.
   PubMed Web of Science ®Google Scholar
• Xie JY, Wei JX, Lv LH, et al. Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma. Cell Commun Signal. 2020;18(1):46.
   PubMed Web of Science ®Google Scholar
• Paredes F, Williams HC, San Martin A. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133–142.
   PubMed Web of Science ®Google Scholar